Adam Rich, Ph.D., an associate professor and Director of Graduate Studies at the Department of Biology at SUNY Brockport, is leading his team in development of a novel zebrafish-based model for human gastrointestinal (GI) motility.
University at Buffalo researchers Alexander N. Cartwright, Ph.D., and Qiaoqiang Gan, Ph.D. have led an effort to make identifying colors easier and more accurate, using a rainbow-colored polymer as a light filter.
The Empire State Stem Cell Board has urged more than $12.1 million in funding be awarded to a collaborative effort among SUNY Upstate Medical University, the School of Medicine and Biomedical Sciences at the University at Buffalo and the University of Rochester Medical Center to develop a new medical treatment for multiple sclerosis (MS).
Ute M. Moll, M.D., Professor of Pathology at Stony Brook University School of Medicine, and her colleagues have uncovered a novel role for the gene p53 beyond cancer.
A long-term study of glass delamination in pharmaceutical vials is being conducted jointly by Gerresheimer Glass Inc. and Alfred University (AU). Gerresheimer is a leading manufacturer of pharmaceutical glass vials, ampoules, and cartridges.
Ron Miles, a distinguished professor and associate dean for research at the Thomas J. Watson School of Engineering and Applied Science at Binghamton University, is leading his team to focus on new miniature microphone technology to address the technological challenges of directional hearing aids.
An interdisciplinary team from Syracuse University is conducting research on how to decipher and control the signaling processes in bacterial multicellular systems and bacteria-host interactions.
Researchers at Cornell have identified two key proteins required for cancer cells to mobilize, and uncovered a new pathway that treatments could block.
Scientists from the University of Rochester Medical Center are part of a team researching a protein known as SAMHD1, which they discovered hinders HIV-1 from infecting white blood cells called macrophages.
Binghamton University mechanical engineer Guangwen Zhou pushes the boundaries of atomic-scale chemistry in his research on oxidation and reduction reactions.
An inter-university research team is working to improve testing and assessment of autism and the corresponding mental disorders that often accompany the disease.
A team of UB researchers has discovered a promising new drug target for Alzheimer's and other neurodegenerative diseases.
Yin's research uses human cues to improve computer user-friendliness.
Inspired by her aunt's real-life battle with rheumatoid arthritis, Rebecca Bader has dedicated her work to creating a drug delivery system for improving RA treatment.
UB electrical-engineering professor Albert Titus, PhD, shed new light on Chris Mullin's "smart" LCD sunglasses.
The University of Rochester Medical Center (URMC) has developed the "DEDiscover" software that simplifies application of math models to scientific problems.